GB0314302D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0314302D0
GB0314302D0 GBGB0314302.1A GB0314302A GB0314302D0 GB 0314302 D0 GB0314302 D0 GB 0314302D0 GB 0314302 A GB0314302 A GB 0314302A GB 0314302 D0 GB0314302 D0 GB 0314302D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0314302.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0314302.1A priority Critical patent/GB0314302D0/en
Publication of GB0314302D0 publication Critical patent/GB0314302D0/en
Priority to PCT/EP2004/006594 priority patent/WO2004111022A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0314302.1A 2003-06-19 2003-06-19 Novel compounds Ceased GB0314302D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0314302.1A GB0314302D0 (en) 2003-06-19 2003-06-19 Novel compounds
PCT/EP2004/006594 WO2004111022A1 (en) 2003-06-19 2004-06-17 3-(1,1-DIOXOTETRAHYDRO-1,2-THIAZIN-2-YL) or 3-(1,1-DOXO-ISOTHIAZOLIDIN-2YL) SUBSTITUTED BENZAMIDE COMPOUNDS AS ASP2 INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314302.1A GB0314302D0 (en) 2003-06-19 2003-06-19 Novel compounds

Publications (1)

Publication Number Publication Date
GB0314302D0 true GB0314302D0 (en) 2003-07-23

Family

ID=27636928

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0314302.1A Ceased GB0314302D0 (en) 2003-06-19 2003-06-19 Novel compounds

Country Status (2)

Country Link
GB (1) GB0314302D0 (en)
WO (1) WO2004111022A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
JP2008526841A (en) 2005-01-10 2008-07-24 アストラゼネカ アクチボラグ Aniline derivatives of isothiazol-3 (2H) -one 1,1-dioxide as a liver X receptor modulator
SE0500055D0 (en) 2005-01-10 2005-01-10 Astrazeneca Ab Therapeutic agents 3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160905B2 (en) * 2001-11-30 2007-01-09 Smithkline Beecham P.L.C. Hydroxyethylene compounds with Asp2 inhibitory activity
TW200304374A (en) * 2001-11-30 2003-10-01 Smithkline Beecham Plc Novel compounds
WO2003106405A1 (en) * 2002-06-01 2003-12-24 Sunesis Pharmaceuticals, Inc. Aspartyl protease inhibitors
GB0228410D0 (en) * 2002-12-05 2003-01-08 Glaxo Group Ltd Novel Compounds

Also Published As

Publication number Publication date
WO2004111022A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
IL175437A0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1596860A4 (en) Novel compounds
EP1648885A4 (en) Novel compounds
GB0305426D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0314302D0 (en) Novel compounds
EP1635834A4 (en) Novel compounds
GB0303467D0 (en) Novel compounds
GB0305163D0 (en) Novel compounds
GB0301872D0 (en) Novel compounds
GB0301955D0 (en) Novel compounds
GB0306209D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0302988D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0304408D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)